- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 10, 2019
Inhibiting translation initiation for androgen receptor-deficient prostate cancer
BioCentury | Dec 8, 2017
Targets & Mechanisms
Pathways emerging from ASH
An analysis of emerging targets at ASH by mechanism
BioCentury | Aug 15, 2016
Emerging Company Profile
Restraining translation
Bantam's eIF4E inhibitors disrupt oncogene translation and cancer metabolism
Items per page:
1 - 7 of 7